A phase 1 first-in-human trial of Friedreich's-ataxia gene therapy
Latest Information Update: 28 Feb 2024
At a glance
- Drugs Friedreich's ataxia gene therapy Voyager Therapeutics (Primary)
- Indications Friedreich's ataxia
- Focus Adverse reactions; First in man
Most Recent Events
- 28 Feb 2024 New trial record
- 26 Feb 2024 According to a Voyager Therapeutics media release, company expects to advance into first-in-human clinical trials in 2025.